Hailing Lu

1.2k total citations
35 papers, 894 citations indexed

About

Hailing Lu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hailing Lu has authored 35 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hailing Lu's work include Ubiquitin and proteasome pathways (7 papers), Lung Cancer Treatments and Mutations (5 papers) and RNA modifications and cancer (5 papers). Hailing Lu is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Lung Cancer Treatments and Mutations (5 papers) and RNA modifications and cancer (5 papers). Hailing Lu collaborates with scholars based in China, United States and Spain. Hailing Lu's co-authors include Qingwei Meng, Li Cai, Yanbin Zhao, Mengru Cao, Jing Hu, Xiaoqun Dong, Xuesong Chen, Hui Pang, Anna Bergamaschi and Benita S. Katzenellenbogen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hailing Lu

33 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hailing Lu China 19 603 286 285 136 94 35 894
Shu‐Biao Wu China 23 841 1.4× 294 1.0× 457 1.6× 131 1.0× 146 1.6× 55 1.2k
Tina Gruosso Canada 12 587 1.0× 337 1.2× 420 1.5× 121 0.9× 193 2.1× 22 1.0k
Bin Qiao China 18 408 0.7× 353 1.2× 188 0.7× 90 0.7× 125 1.3× 36 874
Shanshan Liu China 14 324 0.5× 199 0.7× 218 0.8× 255 1.9× 146 1.6× 43 764
Silvia Ottaviani United Kingdom 15 442 0.7× 217 0.8× 286 1.0× 104 0.8× 52 0.6× 28 843
Chang Yang China 13 498 0.8× 250 0.9× 339 1.2× 115 0.8× 145 1.5× 37 953
De‐Wei Wu Taiwan 22 680 1.1× 234 0.8× 342 1.2× 128 0.9× 153 1.6× 40 1.1k
Haohai Zhang China 17 372 0.6× 201 0.7× 291 1.0× 130 1.0× 87 0.9× 27 784
Chung-Ta Lee Taiwan 15 420 0.7× 197 0.7× 307 1.1× 139 1.0× 72 0.8× 37 866

Countries citing papers authored by Hailing Lu

Since Specialization
Citations

This map shows the geographic impact of Hailing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailing Lu more than expected).

Fields of papers citing papers by Hailing Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailing Lu. The network helps show where Hailing Lu may publish in the future.

Co-authorship network of co-authors of Hailing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hailing Lu. A scholar is included among the top collaborators of Hailing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailing Lu. Hailing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Ziwei, Yu Fu, Hailing Lu, et al.. (2021). Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years. JAMA Pediatrics. 175(7). e210347–e210347. 23 indexed citations
2.
Song, Yang, Yan Shi, Weina Fan, et al.. (2020). Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy. Frontiers in Cell and Developmental Biology. 8. 550–550. 18 indexed citations
3.
Song, Yang, Xuejiao Han, Jing Hu, et al.. (2020). Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling. Frontiers in Oncology. 10. 542007–542007. 6 indexed citations
4.
Lu, Hailing, et al.. (2019). P1.01-44 The Role of Microbiota on the Development of Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S374–S375. 1 indexed citations
5.
Huang, Jian, Xiuwen Lan, Ting Wang, et al.. (2019). Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC. Oncogene. 39(8). 1739–1755. 38 indexed citations
6.
Wang, Ting, Ying Xing, Qingwei Meng, et al.. (2019). Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling. Journal of Experimental & Clinical Cancer Research. 38(1). 174–174. 19 indexed citations
7.
Zhang, Huijuan, Bing Han, Hailing Lu, et al.. (2018). USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma. Cancer Letters. 433. 186–198. 49 indexed citations
8.
Wang, Xiaoyuan, Hang Yin, Hongxia Zhang, et al.. (2018). NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers. Cell Death and Disease. 9(4). 418–418. 27 indexed citations
9.
Wang, Xiaoyuan, Qingwei Meng, Ruishuang Ma, et al.. (2018). miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC. Stem Cell Research & Therapy. 9(1). 327–327. 62 indexed citations
10.
Flowers, Christopher R., Carlos Panizo, Iris Isufi, et al.. (2018). Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular Lymphoma. Blood. 132(Supplement 1). 2892–2892. 6 indexed citations
11.
Pang, Hui, Ting Feng, Hailing Lu, et al.. (2016). Efficacy and Safety of Nedaplatin in Advanced Breast Cancer Therapy. Cancer Investigation. 34(4). 167–172. 4 indexed citations
12.
Bhatia, Shailender, Natalie J. Miller, Hailing Lu, et al.. (2016). Pilot trial of intratumoral (IT) G100, a toll-like receptor-4 (TLR4) agonist, in patients (pts) with Merkel cell carcinoma (MCC): Final clinical results and immunologic effects on the tumor microenvironment (TME).. Journal of Clinical Oncology. 34(15_suppl). 3021–3021. 7 indexed citations
13.
Hu, Jing, Dongdong Yang, Huijuan Zhang, et al.. (2015). USP22 promotes tumor progression and induces epithelial–mesenchymal transition in lung adenocarcinoma. Lung Cancer. 88(3). 239–245. 41 indexed citations
14.
Ning, Jinfeng, Chunhong Li, Jing Hu, et al.. (2015). Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer. Tumor Biology. 37(5). 6331–6336. 33 indexed citations
15.
Wang, Xiaoyuan, Xuesong Chen, Qingwei Meng, et al.. (2015). MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC. Scientific Reports. 5(1). 17618–17618. 58 indexed citations
16.
Cao, Mengru, Yulian Li, Hailing Lu, et al.. (2014). miR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells. Journal of Cancer Research and Clinical Oncology. 140(10). 1661–1670. 29 indexed citations
17.
Gallis, Byron, David R. Goodlett, Yi Yang, et al.. (2013). Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines.. Anticancer Research. 33(1). 123–32. 33 indexed citations
18.
Zhao, Yanbin, Hailing Lu, Yan An, et al.. (2013). ABCC3 as a marker for multidrug resistance in non-small cell lung cancer. Scientific Reports. 3(1). 3120–3120. 64 indexed citations
19.
Lu, Hailing, Qingwei Meng, Wen Yuan, et al.. (2013). Increased EHD1 in non‐small cell lung cancer predicts poor survival. Thoracic Cancer. 4(4). 422–432. 7 indexed citations
20.
Pang, Hui, Hailing Lu, Hongtao Song, et al.. (2013). Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer. Cancer Epidemiology. 37(6). 985–992. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shu‐Biao Wu Breakdown of academic impact, for papers by Tina Gruosso Breakdown of academic impact, for papers by Bin Qiao Breakdown of academic impact, for papers by Shanshan Liu Breakdown of academic impact, for papers by Silvia Ottaviani Breakdown of academic impact, for papers by Chang Yang Breakdown of academic impact, for papers by De‐Wei Wu Breakdown of academic impact, for papers by Haohai Zhang Breakdown of academic impact, for papers by Chung-Ta Lee
Rankless by CCL
2026